InvestorsObserver
×
News Home

Where Does Cortexyme Inc (CRTX) Stock Fall in the Biotechnology Field After It Has Risen 8.93% This Week?

Wednesday, April 21, 2021 11:37 AM | InvestorsObserver Analysts

Mentioned in this article

Where Does Cortexyme Inc (CRTX) Stock Fall in the Biotechnology Field After It Has Risen 8.93% This Week?

Cortexyme Inc (CRTX) is near the middle in its industry group according to InvestorsObserver. CRTX gets an overall rating of 41. That means it scores higher than 41 percent of stocks. Cortexyme Inc gets a 57 rank in the Biotechnology industry. Biotechnology is number 99 out of 148 industries.

Overall Score - 41
CRTX has an Overall Score of 41. Find out what this means to you and get the rest of the rankings on CRTX!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Cortexyme Inc Stock Today?

Cortexyme Inc (CRTX) stock is trading at $39.65 as of 11:20 AM on Wednesday, Apr 21, a gain of $2.53, or 6.82% from the previous closing price of $37.12. The stock has traded between $36.84 and $40.32 so far today. Volume today is low. So far 97,074 shares have traded compared to average volume of 291,510 shares.

Click Here to get the full Stock Score Report on Cortexyme Inc (CRTX) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App